Federal lobbying cost Lilly $2M in first half of year
Eli Lilly and Co. spent nearly $2 million in the first half of 2007 to lobby the federal government, the Associated Press reported today. The Indianapolis-based drug maker lobbied on issues related to patent reform, intellectual property, counterfeiting, prescription drug user fees, health care reform and Medicare, according to the form posted online Aug. 13 […]